Publication | Closed Access

The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells

Histone ModificationsChromatinHematological MalignancyChromatin RemodelingMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderPharmacologyOncologyCell BiologyEpigeneticsCancer ResearchMyeloid Neoplasia